These emerging treatments, Retatrutide, represent a remarkable advancement in managing metabolic dysfunction and potentially other conditions . These drugs are categorized as GLP-1 pathway activators , signifying these substances to emulate the endogenous GLP-1 substance , enhancing insulin release and lowering hunger . Although Semaglutide each wo